Page 2 - Atellica Solution News Today

The organization’s Adlera Lab recently purchased a state-of-the-art blood analyzer from Siemens Healthineers.

The firm said it will cut costs and streamline operations by consolidating its immunoassay and clinical chemistry offerings into the Atellica Solution lineup and phase-out older platforms.

This article outlines a case study of Siemens equipment being used in Surat Thani Hospital, Thailand.

This article outlines a case study of where the atellica Auto QC function was used in Hanoi Medical University Hospital, Vietnam.

Rating: Application Area:sample management "Probably the Best there is and its value for money and more importantly very effective with precision, accuracy and perfection" Review date: 24 Jul 2018 | Atellica® Solution Atellica ® Solution:  Flexible, scalable, automation-ready immunoassay and chemistry analyzers engineered to deliver control and simplicity so you can drive better outcomes. Product availability will vary by country.

Search jobs Immunofluorescence Analyzer Market Global overview 2020 | Trend Analysis & Competition Tracking, Forecast to 2026 Immunoassays are biochemical tests that are used to quantify a specific substance or detect an analyte in body fluid sample or in the blood using an antibody or antigen. Immunoassays are highly specific due to the use of purified antigens and antibodies as reagents and it is sensitive. Common applications of immunoassay include hormones, measurem...

Search jobs 04-Feb-2021 ELISA Analyzer Market-In-Depth Analysis of Business Overview, Current Trends, Prediction Overview, Key Company Profiles | By Service and Service-Provider | Global Industry Forecast – 2026 Enzyme-Linked Immunosorbent Assay (ELISA) is a commonly used analytical biochemistry assay. It uses antibodies and enzyme-mediated color change to detect the presence of either antigen (proteins, peptides, and hormones) or antibody in a sam...

During the financial crisis of 2008, the world had the opportunity to shape a more sustainable economy. According to economist Nicholas Stern, the economic and technological conditions at the time would have made it easier to make progress on climate change. But we failed to grasp it. Twelve years on, we find ourselves in an ...

The medical technology sector has performed well during 2020, benefitting from broader healthcare tailwinds. The sector has many high-quality growth names that are well-placed to gain 2021 that Bank of America prefers over some of the big value names. Here are the 16 medtech stocks BofA thinks you should own going into 2021. Medical technology stocks performed strongly in 2020, benefitting from the wider healthcare tailwinds caused by the pandemic, and this is set to continue into 2021 for comp...